NICE draft guidance recommends abemaciclib for advanced breast cancer
NICE has published draft guidance on Thursday (August 12) which recommends twice-daily pill abemaciclib as an option for adults with a type of breast...
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc